Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2023-01-12 00:00:00 ET · period of report 2023-01-10 · accession 0001209191-23-003108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-12 | 2023-01-10 | ARWR | Ferrari Mauro | Dir | A - Grant | $0.00 | +7,867 | 50.8K | +18% | $0 |
| D | 2023-01-12 | 2023-01-10 | ARWR | Ferrari Mauro | Dir | A - Grant | $0.00 | +4,593 | 4,593 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-10 | A | A | 7,867 | $0.00 | 50,838 | D | — | — | (F1) Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date. |
| 2 | Derivative | Common Stock | 2023-01-10 | A | A | 4,593 | $0.00 | 4,593 | D | $33.03 · 2024-01-10 to 2033-01-10 | 4,593 Common Stock | (F2) Represents options, which will vest in one installment on the first anniversary of the grant date. |